Anfield Capital Management, LLC

Position in MRK — Merck & Co., Inc.

CIK 1602020 IRVINE, CA

Position in MRK

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$160,948

+$127,476 QoQ

Shares Held

1,338

+320.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Anfield Capital Management, LLC holds $889,493 across 12 Drug Manufacturers - General names. MRK ranks #2 (18.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	281	$258,455
2	MRK	Merck & Co., Inc. This page	1,338	$160,948
3	GSK	GSK plc	1,852	$102,211
4	JNJ	Johnson & Johnson	342	$83,598
5	AZN	Astrazeneca PLC	385	$75,929
6	PFE	Pfizer Inc	2,543	$71,407
7	SNY	Sanofi	1,286	$61,959
8	NVS	Novartis AG	284	$43,381

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$160,948	1,338	+320.8%	Shares	Defined	2026-05-12
2025-12-31	$33,472	318	+4.3%	Shares	Defined	2026-02-03
2025-09-30	$25,598	305	-5.0%	Shares	Defined	2025-11-12
2025-06-30	$25,410	321	+12.2%	Shares	Defined	2025-08-11
2025-03-31	$25,671	286	0.0%	Shares	Defined	2025-05-13
2024-12-31	$28,451	286	-5.0%	Shares	Defined	2025-02-05
2024-09-30	$34,181	301	+71.0%	Shares	Defined	2024-11-08
2024-06-30	$21,788	176	-89.0%	Shares	Defined	2024-07-31
2022-12-31	$178,074	1,605	-59.0%	Shares	Defined	2023-02-01
2022-09-30	$337,159	3,915	+3.6%	Shares	Defined	2022-11-09
2022-06-30	$344,622	3,780	+16.7%	Shares	Defined	2022-08-09
2022-03-31	$265,842	3,240	+1670.5%	Shares	Defined	2022-05-13
2021-06-30	$14,231	183	-97.5%	Shares	Defined	2021-08-03
2020-06-30	$570,231	7,374	+1.8%	Shares	Defined	2020-08-11
2020-03-31	$557,276	7,243	—	Shares	Defined	2020-05-07
No filing history on record for this holder in this stock.